Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Dow Futures Up 104 Pts; Earnings Deluge in Focus

Published 10/27/2020, 07:56 AM
Updated 10/27/2020, 07:58 AM
© Reuters
EUR/USD
-
XAU/USD
-
US500
-
DJI
-
CAT
-
MSFT
-
LLY
-
MRK
-
MMM
-
PFE
-
GC
-
LCO
-
ESH25
-
CL
-
1YMH25
-
NQH25
-
IXIC
-

By Peter Nurse

Investing.com - U.S. stocks are seen opening higher Tuesday, bouncing to a degree after Monday’s sharp losses, as investors digest a slew of key earnings amid concern over the rising number of coronavirus cases.

At 7 AM ET (1200 GMT), S&P 500 Futures traded 16 points, or 0.5%, higher, the Dow Futures contract rose 104 points, or 0.4%, while Nasdaq 100 Futures climbed 65 points, or 0.6%. 

Investors will likely focus Tuesday on the release of a raft of key earnings. Eli Lilly  (NYSE:LLY) stock fell 4.6% in premarket trading after reporting a 4% drop in profit, only a day after acknowledging its experimental antibody treatment for Covid-19 had failed to produce the desired results. Rival drug producer Merck (NYSE:MRK) rose 1.3% after handily beating expectations for earnings, while Pfizer (NYSE:PFE) stock slipped after the company said it wasn't yet ready to release preliminary data from late-stage trials of its Covid-19 drug.  

Also in the spotlight are numbers from Caterpillar (NYSE:CAT), where profit fell 54%, slightly less than expected, and 3M Company (NYSE:MMM). Software giant Microsoft (NASDAQ:MSFT) starts a big week for the tech giants, even as they face increasing antitrust scrutiny.

Looking at economic data, updates are due for durable goods orders for September, house price data and the Richmond Fed’s regional business survey; But the Conference Board’s consumer sentiment index for October is likely to be the main release, as a sign that there is support for spending, which drives two-thirds of U.S. economic output. 

Wall Street closed substantially lower on Monday, with the Dow Jones Industrial Average falling 2.3%, its worst day since early September, the S&P 500 losing 1.9%, while the Nasdaq Composite dropped 1.6%. 

Driving the recent weakness has been concerns over the resurgence of Covid-19 cases in the northern hemisphere as the winter draws nearer. Europe has been hard hit, with a number of countries resorting to new containment procedures, but the U.S. has also reported records for new daily cases. 

In just one week, the United States has seen an increase of nearly half a million cases, leading some local and state officials to rein in their reopening plans, as hospital capacity constraints start to loom.

Meanwhile the chances of a new coronavirus relief deal seems very unlikely with Majority Leader Mitch McConnell adjourning the Senate until November 9.

Oil prices edged higher Tuesday, rebounding after Monday’s hefty losses, but the surge in coronavirus cases in the U.S. and Europe means sentiment remains gloomy.

Hurricane Zeta is due to make U.S. landfall on Wednesday, with rigs and refineries shutting down in preparation for its arrival, while traders also await crude oil supply data from the American Petroleum Institute, due later in the session.

U.S. crude futures traded 0.8% higher at $38.88 a barrel, while the international benchmark Brent contract rose 0.8% to $41.12. Both contracts fell more than 3% on Monday.

Elsewhere, gold futures fell 0.1% to $1,905.05/oz, while EUR/USD traded 0.2% higher at 1.1828.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.